MR-Based Correction of Brain PET Measurements for Heterogeneous Gray Matter Radioactivity Distribution

Partial volume and mixed tissue sampling errors can cause significant inaccuracy in quantitative positron emission tomographic (PET) measurements. We previously described a method of correcting PET data for the effects of partial volume averaging on gray matter (GM) quantitation; however, this method may incompletely correct GM structures when local tissue concentrations are highly heterogeneous. We have extended this three-compartment algorithm to include a fourth compartment: a GM volume of interest (VOI) that can be delineated on magnetic resonance (MR) imaging. Computer simulations of PET images created from human MR data demonstrated errors of up to 120% in assigned activity values in small brain structures in uncorrected data. Four-compartment correction achieved full recovery of a wide range of coded activity in GM VOIs such as the amygdala, caudate, and thalamus. Further validation was performed in an agarose brain phantom in actual PET acquisitions. Implementation of this partial volume correction approach in [18F]fluorodeoxyglucose and [11C]-carfentanil PET data acquired in a healthy elderly human subject was also performed. This newly developed MR-based partial volume correction algorithm permits the accurate determination of the true radioactivity concentration in specific structures that can be defined by MR by accounting for the influence of heterogeneity of GM radioactivity.

[1]  C. Pelizzari,et al.  Retrospective geometric correlation of MR, CT, and PET images. , 1988, Radiology.

[2]  D G Brunder,et al.  Measurement of brain compartment volumes in MR using voxel composition calculations. , 1991, Journal of computer assisted tomography.

[3]  A. Alavi,et al.  Positron emission tomography in aging and dementia: effect of cerebral atrophy. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  J. Haxby,et al.  Quantitative computed tomography in dementia of the Alzheimer type , 1986, Neurology.

[5]  Michael E. Phelps,et al.  Quantitation in Positron Emission Computed Tomography , 1980 .

[6]  L. Axel,et al.  Agarose as a tissue equivalent phantom material for NMR imaging. , 1986, Magnetic resonance imaging.

[7]  R. Kessler,et al.  Analysis of emission tomographic scan data: limitations imposed by resolution and background. , 1984, Journal of computer assisted tomography.

[8]  E. Skinhøj,et al.  In vivo measurements of the relative weights of gray and white matter in the human brain , 1966, Neurology.

[9]  Gwenn S. Smith,et al.  Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. , 1991, Radiology.

[10]  S. Strother,et al.  Graphical Analysis of MR Feature Space for Measurement of CSF, Gray‐Matter, and White‐Matter Volumes , 1993, Journal of computer assisted tomography.

[11]  Alan C. Evans,et al.  MRI-PET Correlation in Three Dimensions Using a Volume-of-Interest (VOI) Atlas , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  C. Coffey,et al.  Quantitative cerebral anatomy of the aging human brain , 1992, Neurology.

[13]  D Wyper,et al.  A quantitative index of ventricular and extraventricular intracranial CSF volumes using MR imaging. , 1986, Journal of computer assisted tomography.

[14]  J C Mazziotta,et al.  Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.

[15]  E. Hoffman,et al.  Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.

[16]  J. Pratt,et al.  Flumazenil induces localised increases in glucose utilization during diazepam withdrawal in rats , 1993, Brain Research.

[17]  Peter Herscovitch,et al.  Correction of Positron Emission Tomography Data for Cerebral Atrophy , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  D Wyper,et al.  USE OF MAGNETIC RESONANCE IMAGING TO MEASURE INTRACRANIAL CEREBROSPINAL FLUID VOLUME , 1986, The Lancet.

[19]  K O Lim,et al.  Decreased gray matter in normal aging: an in vivo magnetic resonance study. , 1992, Journal of gerontology.

[20]  J A Corsellis,et al.  VARIATION WITH AGE IN THE VOLUMES OF GREY AND WHITE MATTER IN THE CEREBRAL HEMISPHERES OF MAN: MEASUREMENTS WITH AN IMAGE ANALYSER , 1980, Neuropathology and applied neurobiology.

[21]  A. Alavi,et al.  Analysis of brain and cerebrospinal fluid volumes with MR imaging. Part I. Methods, reliability, and validation. , 1991, Radiology.

[22]  A. Alavi,et al.  Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  H. Mayberg,et al.  Correction of PET Data for Partial Volume Effects in Human Cerebral Cortex by MR Imaging , 1990, Journal of computer assisted tomography.

[24]  J. Zubieta,et al.  Influence of spatially heterogeneous background activity on "hot object" quantitation in brain emission computed tomography. , 1996, Journal of computer assisted tomography.

[25]  M E Raichle,et al.  Regional Correction of Positron Emission Tomography Data for the Effects of Cerebral Atrophy , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  Gwenn S. Smith,et al.  Gray‐matter degeneration in presenile alzheimer's disease , 1989, Annals of neurology.

[27]  H. Holcomb,et al.  Anatomical localization for PET using MR imaging. , 1990, Journal of computer assisted tomography.

[28]  K. Lim,et al.  Segmentation of MR Brain Images into Cerebrospinal Fluid Spaces, White and Gray Matter , 1989, Journal of computer assisted tomography.

[29]  I Kapouleas,et al.  Registration of three-dimensional MR and PET images of the human brain without markers. , 1991, Radiology.

[30]  Alan A. Wilson,et al.  Mu‐opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy , 1988, Annals of neurology.

[31]  R. Hammer,et al.  Gradual tolerance of metabolic activity is produced in mesolimbic regions by chronic cocaine treatment, while subsequent cocaine challenge activates extrapyramidal regions of rat brain , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  A. Alavi,et al.  Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  B Horwitz,et al.  Relation of measured brain glucose utilisation and cerebral atrophy in man. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[34]  Jerry L Prince,et al.  Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  A. Alavi,et al.  Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. , 1991, Radiology.

[36]  Dean F. Wong,et al.  Imaging Opiate Receptors in the Human Brain by Positron Tomography , 1985, Journal of computer assisted tomography.